G1 Therapeutics

0 followers


G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).

Industries

Headquarters

NC, United States

Employees

51-200

Links


Org chart

Raj Malik
Chief Medical Officer
Monica Thomas
General Counsel & Chief Compliance Office
Darlene Burns
Director, Key Customer Marketing
Shannon Lim
Medical Science Liaison
Bobirjon Mukamilov
Financial Planning and Analysis Manager
Zaida Padron
Oncology Account Manager
Olu O. Oyeneye
Sr Infrastructure /DevOps Eng.
Mike Townsend
Principal Solutions Architect

Board & advisors